Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

159
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Communicating the Diagnosis of Type 1 vs Type 2 Myocardial Infarction.

JACC. Advances·2026
Same author

Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review.

Circulation. Population health and outcomes·2026
Same author

State Expansions in Medicaid Financial Assistance for Low-Income Medicare Beneficiaries: Changes in Enrollment and Use.

Health services research·2026
Same author

Medicaid Retention After Transition to Medicare Among Adults With Expansion Coverage.

JAMA network open·2026
Same author

Validity of the International Classification of Diseases, Tenth Revision codes in diagnosing myocardial infarction subtypes.

American heart journal·2026
Same author

Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay.

The journal of applied laboratory medicine·2026
Same journal

Regionalization of Mitral Transcatheter Edge-to-Edge Repair: Balancing Access and Expertise.

Circulation. Cardiovascular quality and outcomes·2025
Same journal

Making Your Blood Boil: Challenges and Opportunities for Using Emergency Department Data to Understand the Impact of Structural Inequities on Health.

Circulation. Cardiovascular quality and outcomes·2025
Same journal

Association Between Cardiac Rehabilitation and 1-Year Mortality by Frailty Level in Medicare Beneficiaries.

Circulation. Cardiovascular quality and outcomes·2025
Same journal

Association of Neighborhood Violent Crime With Hypertension-Related Emergency Department Visits in Chicago.

Circulation. Cardiovascular quality and outcomes·2025
Same journal

Improving Quality in Cardiac Arrest via Resuscitation Academy Training (IQ-CART): Study Protocol for a Mixed-Methods Study With a Focus on Low-Performing EMS Agencies.

Circulation. Cardiovascular quality and outcomes·2025
Same journal

From Referral to Recovery: Maximizing Enrollment and Participation in Cardiac Rehabilitation.

Circulation. Cardiovascular quality and outcomes·2025
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims

Jason H Wasfy1, Mary Price2, Sharon-Lise T Normand3

  • 1Cardiology Division (J.H.W., J.L.J., C.P.M.), Massachusetts General Hospital, Harvard Medical School, Boston.

Circulation. Cardiovascular Quality and Outcomes
|January 19, 2024
PubMed
Summary
This summary is machine-generated.

A new algorithm can distinguish between type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) in health records. This improves quality assessment by accurately classifying T2MI versus T1MI cases.

Keywords:
Medicareclassificationepidemiologyhospitalizationmyocardial infarction

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K

Related Experiment Videos

Last Updated: Jul 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K

Area of Science:

  • Cardiology
  • Health Informatics
  • Health Services Research

Background:

  • Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) have distinct patient demographics, comorbidities, treatments, and outcomes.
  • Accurate quality and outcomes assessment necessitates reliable differentiation between T1MI and T2MI within administrative claims data.

Purpose of the Study:

  • To develop and validate a classification algorithm for distinguishing T1MI from T2MI in administrative claims data.
  • To enable more precise quality and outcomes assessments for acute myocardial infarction.

Main Methods:

  • Utilized Medicare accountable care organization data (2018-2021) from a New England healthcare system.
  • Developed a classification algorithm using International Classification of Diseases, Tenth Revision codes, patient demographics, and comorbidities.
  • Assessed algorithm performance using a C-statistic and compared classified T2MI with observed T2MI.

Main Results:

  • The study included 7759 hospitalizations for myocardial infarction (46.5% T1MI, 53.5% T2MI).
  • Factors associated with higher odds of T2MI included female gender, Black race, COVID-19 diagnosis, and hypertensive emergency.
  • The classification algorithm achieved a C-statistic of 0.83, indicating good discriminatory power.

Conclusions:

  • A straightforward classification algorithm can effectively differentiate between T1MI and T2MI hospitalizations.
  • This algorithm can be applied to claims data both before and after the introduction of the T2MI code.
  • Improved classification facilitates more accurate longitudinal assessments of acute myocardial infarction quality and outcomes.